The costs of overweight and obesity-related diseases in the Brazilian public health system: cross-sectional study

BMC Public Health

Denizar Vianna Araujo²  Camila Pepe Ribeiro de Souza⁵  Thainá Alves Malhão³  Gabriela de Azevedo Abreu¹  Laura Augusta Barufaldi¹  Evandro Silva Freire Coutinho⁴  Luciana Bahia² 

[1] Institute for Studies in Public Health, Federal University of Rio de Janeiro (UFRJ), Blv. Horácio Macedo, No number - Fundão Island, University City, ZIP 21941-598, Rio de Janeiro/RJ, Brazil;Internal Medicine Department, State University of Rio de Janeiro (UERJ) and National Institute of Science and Technology for Health Technology Assessment (IATS) – CNPq/Brazil, Blv. 28 de Setembro 77 – 3rd floor – room 329, Vila Isabel, ZIP 20551-030, Rio de Janeiro/RJ, Brazil;City Department of Health and Civil Defense of Rio de Janeiro (SMSDC-RJ), Afonso Cavalcanti Street, 455, 8th floor, room 801, New Town, ZIP 20211-110, Rio de Janeiro/RJ, Brazil;National School of Public Health, Oswaldo Cruz Foundation (Fiocruz), Leopoldo Bulhões Street, 1480, Manguinhos, ZIP 21041-210, Rio de Janeiro/RJ, Brazil;Medinsight Decisions in Health Care, Hollywood Street, 330, Brooklin, ZIP 04564-040, São Paulo/SP, Brazil

关键词: Brazil;    Costs;    Obesity;    Overweight;   

Others  :  1163535
DOI  :  10.1186/1471-2458-12-440

 received in 2012-03-12, accepted in 2012-05-16,  发布年份 2012

【 摘 要 】

Background

Obesity is a major global epidemic and a burden to society and health systems. It is well known risk factor for a number of chronic medical conditions with high morbidity and mortality. This study aimed to provide an estimate of the direct costs associated to outpatient and inpatient care of overweight and obesity related diseases in the perspective of the Brazilian Health System (SUS).

Methods

Population attributable risk (PAR) was calculated for selected diseases related to overweight and obesity and with the following parameters: Relative risk (RR) ≥ 1.20 or RR ≥1.10 and < 1.20, but important problem of public health due its high prevalence. After a broad search in the literature, two meta-analysis were selected to provide RR for PAR calculation. The prevalence rates of overweight and obesity in Brazilians with ≥18 years were obtained from large national survey. The national health database (DATASUS) was used to estimate the annual cost of the Brazilian Unified Health System (SUS) with the diseases included in the analysis. The extracted values were stratified by sex, type of service (inpatient or outpatient care) and year. Data were collected from 2008 to 2010 and the results reflect the average of 3 years. Brazilian costs were converted into US dollars during the analysis using a purchasing power parity basis (2010).

Results

The estimated total costs in one year with all diseases related to overweight and obesity are US$ 2,1 billion; US$ 1,4 billion (68.4% of total costs) due to hospitalizations and US$ 679 million due to ambulatory procedures. Approximately 10% of these cost is attributable to overweight and obesity.

Conclusion

The results confirm that overweight and obesity carry a great economic burden for Brazilian health system and for the society. The knowledge of these costs will be useful for future economic analysis of preventive and treatment interventions.

【 授权许可】

   
2012 Bahia et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]WHO: Obesity-preventing and managing the global epidemic. World Health Organization, Geneva; 1997.
• [2]Vigitel Brasil 2006: protective and risk factors for chronic diseases by telephone survey. , ; cited 2012 Dec 5. http://bvsms.saude.gov.br/bvs/publicacoes/relatorio_vigitel_2006_marco_2007.pdf webcite
• [3]Vigitel Brazil 2010: protective and risk factors for chronic diseases by telephone survey. , ; cited 2012 Dec 5. http://portal.saude.gov.br/portal/arquivos/pdf/vigitel_180411.pdf webcite
• [4]Polednak AP: Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers. Cancer Detect Prev 2008, 32(3):190-199.
• [5]Sturm R, Wells KB: Does obesity contribute as much to morbidity as poverty or smoking? Public Health 2001, 115:229-235.
• [6]Levin ML: The occurrence of lung cancer in men. Acta Uno Internationalis Contra Cancrum 1953, 9:532-541.
• [7]Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansson E, Grimshaw J, Henry DA, Boers M: AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol 2009, 62:1013-1020.
• [8]Guh D, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH: The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009, 9:88-20. BioMed Central Full Text
• [9]Larson SC, Wolk A: Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer 2007, 96:1457-1461.
• [10]; cited 2012 January 10. DATASUS www.datasus.gov.br/ webcite
• [11]; cited 2012 Feb 10. Word bank http://data.worldbank.org/ webcite
• [12]Rezende K, Ferraz MB, Malerbi DA: Direct costs and outcomes for inpatients with diabetes mellitus and foot ulcers in a developing country: The experience of the public health system of Brazil. Diab Metab Synd: Clin Res Rev 2009, 3(4):228-232.
• [13]Christensen MC, Valiente R, Silva GS, Lee WC, Dutcher S, Guimarães Rocha MS, Massaro A: Acute treatment costs of stroke in Brazil. Neuroepidemiology 2009, 32:142-149.
• [14]Sichieri R, Nascimento S, Coutinho W: The burden of hospitalization due to overweight and obesity in Brazil. Cad Saude Publica 2007, 23(7):1721-1727.
• [15]Bahia L, Araujo DV, Schaan B, Dib SA, Negrato CA, Leão MPS, Ramos AJS, Forti AC, Gomes MB, Foss MC, Monteiro RA, Sartorelli D, Franco LJ: The costs of Type 2 diabetes mellitus outpatient care in the brazilian public health system. Value Health 2011, 14:S137-S140.
• [16]Araujo DV, Tavares R, Veríssimo L, Ferraz MB, Mesquita ET: Custo da Insuficiência Cardíaca no Sistema Único de Saúde. Arq Bras Cardiol 2005, 84(5):422-427.
• [17]Wang CY, McPherson K, Marsh T, Gortmaker SL, Brown M: Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011, 378(27):815-825.
• [18]; DATASUS http://www2.datasus.gov.br/DATASUS/index.php?area=0701&item=1&acao=11 webcite
• [19]; cited 2012 Dec 5. IBGE http://www.ibge.gov.br/home/estatistica/indicadores/pib/defaultcnt.shtm webcite
• [20]Müller-Riemenschneider F, Reinhold T, Berghöfer A, Willich SN: Health economic burden of obesity in Europe. Eur J Epidemiol 2008, 23:499-509.
• [21]Allender A, Rayner M: The burden of overweight and obesity-related ill health in the UK. Obes Rev 2007, 8:467-473.
• [22]Kang JH, Jeong BG, Cho YG: Socioeconomic costs of overweight and obesity in Korean adults. J Korean Med Sci 2011, 26:1533-1540.
• [23]; CDC http://www.cdc.gov/obesity/data/trends.HTML#County webcite
• [24]Finkelstein EA, Trogdon JG, Cohen JW, Dietz W: Annual medical spending attributable to obesity: Payer- and service-specific estimates. Health Aff 2009, 28(5):822-831.
• [25]Hammond RA, Levine R: The economic impact of obesity in the United States. Diabetes Metab Syndr Obes 2010, 3:285-295.